Cargando…

Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D

Acidosis is a significant feature of the tumor microenvironment in glioma, and it is closely related to multiple biological functions of cancer stem cells. Here, we found that the self-renewal ability, the mitochondrial activity and ATP production were elevated in stem cell-like glioma cells (SLCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Peishan, Li, Shanshan, Tian, Ningyu, Wu, Fan, Hu, Yan, Li, Dengke, Qi, Yingjiao, Wei, Zhizhong, Wei, Qunfang, Li, Yanchao, Yin, Bin, Jiang, Tao, Yuan, Jiangang, Qiang, Boqin, Han, Wei, Peng, Xiaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328565/
https://www.ncbi.nlm.nih.gov/pubmed/30631035
http://dx.doi.org/10.1038/s41419-018-1242-1
Descripción
Sumario:Acidosis is a significant feature of the tumor microenvironment in glioma, and it is closely related to multiple biological functions of cancer stem cells. Here, we found that the self-renewal ability, the mitochondrial activity and ATP production were elevated in stem cell-like glioma cells (SLCs) under acidic microenvironment, which promoted and maintained the stemness of SLCs. Under acidosis, 25-hydroxy vitamin D(3)-24-hydroxylase (CYP24A1) was upregulated and catalyzed the fast degradation of 1α,25(OH)(2)D(3). We further revealed that the active form of vitamin D (1α,25(OH)(2)D(3)) could inhibit the expression of stemness markers, attenuate acidosis-induced increase of self-renewal ability and mitochondrial respiration in stem cell-like glioma cells. Our study indicates that the acidosis–CYP24A1–vitamin D pathway may be a key regulator of the cancer stem cell phenotype in malignant glioma and point out the potential value for the utilization of vitamin D to target cancer stem cells and to restrain the growth of malignant glioma in the future.